Want to see GSK full AI Analyst Report?
ETFs with GlaxoSmithKline (GSK) Exposure
The following ETFs maintain exposure to GlaxoSmithKline (GSK). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
62 ETFs Hold GlaxoSmithKline (GSK)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in GSK |
|---|---|---|---|---|---|---|
| GSKH | GSK plc ADRhedged | $685.22K | 0.19% | 96.95% | $674.18K | <0.01% |
| PPH | VanEck Pharmaceutical ETF | $1.08B | 0.36% | 4.24% | $45.51M | 0.05% |
| XGEN | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD | $14.78M | 0.36% | 3.93% | $599.49K | <0.01% |
| HIG.U | Brompton Global Healthcare Income & Growth ETF USD Trust Unit | $875.23K | 0.96% | 3.55% | $2.49M | <0.01% |
| HIG | Brompton Global Healthcare Income & Growth ETF | $71.88M | 0.96% | 3.55% | $2.49M | <0.01% |
| KEAT | Keating Active ETF | $119.36M | 0.85% | 3.50% | $4.17M | <0.01% |
| IDVZ | Opal International Dividend Income ETF | $201.52M | 0.75% | 3.15% | $6.34M | <0.01% |
| DIVY | Sound Equity Income ETF | $29.82M | 0.45% | 3.05% | $910.51K | <0.01% |
| VIRS | ― | ― | ― | 2.83% | $112.73K | <0.01% |
| HEAL | ― | ― | ― | 2.57% | $63.56K | <0.01% |
| UDI | USCF Dividend Income Fund | $3.17M | 0.65% | 2.46% | $77.78K | <0.01% |
| MEDX | Horizon Kinetics Medical ETF | $17.76M | 0.85% | 2.44% | $433.25K | <0.01% |
| GMOI | GMO International Value ETF | $694.18M | 0.60% | 2.35% | $16.28M | 0.02% |
| EDGF | Brompton European Dividend Growth ETF | $42.82M | 1.06% | 2.13% | $931.64K | <0.01% |
| BDIV | AAM Brentview Dividend Growth ETF | $7.33M | 0.49% | 1.99% | $145.65K | <0.01% |
| DIVD | Altrius Global Dividend ETF Altrius Global Divid ETF | $25.87M | 0.49% | 1.98% | $512.50K | <0.01% |
| PHW | Purpose Intl TacHgEq | $2.02M | 1.57% | 1.97% | $266.67K | <0.01% |
| BINV | Brandes International ETF | $540.27M | 0.70% | 1.67% | $9.12M | <0.01% |
| LCIV | Logan Capital International ETF | $20.25M | 0.99% | 1.64% | $332.87K | <0.01% |
| CBR1 | First Trust IPOX Europe Equity Opportunities UCITS ETF EUR | $1.24M | 0.73% | 1.62% | $19.96K | <0.01% |
| FPXE | First Trust IPOX Europe Equity Opportunities ETF | $4.80M | 0.70% | 1.62% | $76.59K | <0.01% |
| GINX | SGI Enhanced Global Income ETF | $107.18M | 1.02% | 1.60% | $1.71M | <0.01% |
| FDWM | ― | ― | ― | 1.44% | $66.96K | <0.01% |
| HWGV | Hotchkis & Wiley Global Value Fund ETF | $2.54M | 0.70% | 1.44% | $592.78K | <0.01% |
| FBCV | Fidelity Blue Chip Value ETF | $198.47M | 0.57% | 1.28% | $2.38M | <0.01% |
| ABIU | ― | ― | ― | 1.14% | $286.08K | <0.01% |
| ABIE | ― | ― | ― | 1.14% | $286.08K | <0.01% |
| RODE | ― | ― | ― | 1.03% | $173.16K | <0.01% |
| RODM | Hartford Multifactor Developed Markets (ex-US) ETF | $1.68B | 0.29% | 0.90% | $14.95M | 0.02% |
| FFLV | Fidelity Fundamental Large Cap Value ETF | $18.82M | 0.38% | 0.81% | $152.51K | <0.01% |
| AQEC | AQE Core ETF | $609.20M | 0.49% | 0.69% | $4.21M | <0.01% |
| GQEU | Goldman Sachs Alpha Enhanced Europe Equity Active UCITS ETF AccumEUR | $614.57M | 0.77% | 0.65% | $4.00M | <0.01% |
| GDEU | Goldman Sachs Alpha Enhanced Europe Equity Active UCITS ETF EUR | $105.28K | 0.91% | 0.65% | $4.00M | <0.01% |
| ACLU | ― | ― | ― | 0.62% | $115.08K | <0.01% |
| ACLE | ― | ― | ― | 0.62% | $115.08K | <0.01% |
| LST | Leuthold Select Industries ETF | $218.01M | 0.65% | 0.62% | $1.35M | <0.01% |
| AVEU | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | 0.62% | $245.44K | <0.01% |
| FFLC | Fidelity UCITS ICAV - Fidelity US Fundamental Large Cap Core UCITS ETF USD | $87.01M | 0.40% | 0.59% | $502.18K | <0.01% |
| AVIV | Avantis International Large Cap Value ETF | $2.07B | 0.25% | 0.57% | $11.83M | 0.01% |
| FFLC | Fidelity Fundamental Large Cap Core ETF | $1.26B | 0.38% | 0.56% | $7.03M | <0.01% |
| AVSD | Avantis Responsible International Equity ETF | $376.48M | 0.23% | 0.49% | $1.85M | <0.01% |
| FENI | Fidelity Enhanced International ETF | $11.69B | 0.28% | 0.48% | $55.68M | 0.06% |
| TOUS | T. Rowe Price International Equity ETF | $1.71B | 0.50% | 0.46% | $7.84M | <0.01% |
| SPWO | SP Funds S&P World (ex-US) ETF | $244.75M | 0.55% | 0.45% | $1.11M | <0.01% |
| AVNC | Avantis All International Core Equity ETF | $99.60M | 0.27% | 0.40% | $401.27K | <0.01% |
| FVD | First Trust Value Line Dividend Index Fund | $8.05B | 0.62% | 0.40% | $32.13M | 0.03% |
| FUD | 1st Tr AlphaUSDiv Un | $7.73M | 0.79% | 0.39% | $30.58K | <0.01% |
| AVDE | Avantis International Equity ETF | $19.65B | 0.23% | 0.36% | $70.71M | 0.07% |
| CADE | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | 0.33% | $1.17M | <0.01% |
| DDXM | Dimensional Funds ICAV - Dimensional Global ex US Core Equity Market UCITS ETF USD Acc | ― | 0.22% | 0.33% | $577.69K | <0.01% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.30% | $3.44M | <0.01% |
| TIER | T. Rowe Price International Equity Research ETF | $137.11M | 0.38% | 0.27% | $375.61K | <0.01% |
| DXIV | Dimensional International Vector Equity ETF | $232.54M | 0.30% | 0.26% | $596.38K | <0.01% |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | 0.11% | $13.47M | 0.01% |
| FTLS | First Trust Long/Short Equity ETF | $2.66B | 1.38% | 0.10% | $2.71M | <0.01% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | 0.10% | $864.80K | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | 0.10% | $864.80K | <0.01% |
| DIHP | Dimensional International High Profitability ETF | $6.60B | 0.27% | 0.08% | $4.96M | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | 0.06% | $1.35M | <0.01% |
| GEQ | Cambria Global EW 2 ETF | $205.96M | 0.27% | 0.06% | $125.69K | <0.01% |
| DFSI | Dimensional International Sustainability Core 1 ETF | $1.18B | 0.24% | 0.02% | $270.51K | <0.01% |
| DFIC | Dimensional International Core Equity 2 ETF | $15.36B | 0.22% | 0.01% | $1.69M | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in GSK |
|---|---|---|---|---|---|---|
| GSKH | 96.95% | GSK plc ADRhedged | $685.22K | 0.19% | $674.18K | <0.01% |
| PPH | 4.24% | VanEck Pharmaceutical ETF | $1.08B | 0.36% | $45.51M | 0.05% |
| XGEN | 3.93% | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD | $14.78M | 0.36% | $599.49K | <0.01% |
| HIG.U | 3.55% | Brompton Global Healthcare Income & Growth ETF USD Trust Unit | $875.23K | 0.96% | $2.49M | <0.01% |
| HIG | 3.55% | Brompton Global Healthcare Income & Growth ETF | $71.88M | 0.96% | $2.49M | <0.01% |
| KEAT | 3.50% | Keating Active ETF | $119.36M | 0.85% | $4.17M | <0.01% |
| IDVZ | 3.15% | Opal International Dividend Income ETF | $201.52M | 0.75% | $6.34M | <0.01% |
| DIVY | 3.05% | Sound Equity Income ETF | $29.82M | 0.45% | $910.51K | <0.01% |
| VIRS | 2.83% | ― | ― | ― | $112.73K | <0.01% |
| HEAL | 2.57% | ― | ― | ― | $63.56K | <0.01% |
| UDI | 2.46% | USCF Dividend Income Fund | $3.17M | 0.65% | $77.78K | <0.01% |
| MEDX | 2.44% | Horizon Kinetics Medical ETF | $17.76M | 0.85% | $433.25K | <0.01% |
| GMOI | 2.35% | GMO International Value ETF | $694.18M | 0.60% | $16.28M | 0.02% |
| EDGF | 2.13% | Brompton European Dividend Growth ETF | $42.82M | 1.06% | $931.64K | <0.01% |
| BDIV | 1.99% | AAM Brentview Dividend Growth ETF | $7.33M | 0.49% | $145.65K | <0.01% |
| DIVD | 1.98% | Altrius Global Dividend ETF Altrius Global Divid ETF | $25.87M | 0.49% | $512.50K | <0.01% |
| PHW | 1.97% | Purpose Intl TacHgEq | $2.02M | 1.57% | $266.67K | <0.01% |
| BINV | 1.67% | Brandes International ETF | $540.27M | 0.70% | $9.12M | <0.01% |
| LCIV | 1.64% | Logan Capital International ETF | $20.25M | 0.99% | $332.87K | <0.01% |
| CBR1 | 1.62% | First Trust IPOX Europe Equity Opportunities UCITS ETF EUR | $1.24M | 0.73% | $19.96K | <0.01% |
| FPXE | 1.62% | First Trust IPOX Europe Equity Opportunities ETF | $4.80M | 0.70% | $76.59K | <0.01% |
| GINX | 1.60% | SGI Enhanced Global Income ETF | $107.18M | 1.02% | $1.71M | <0.01% |
| FDWM | 1.44% | ― | ― | ― | $66.96K | <0.01% |
| HWGV | 1.44% | Hotchkis & Wiley Global Value Fund ETF | $2.54M | 0.70% | $592.78K | <0.01% |
| FBCV | 1.28% | Fidelity Blue Chip Value ETF | $198.47M | 0.57% | $2.38M | <0.01% |
| ABIU | 1.14% | ― | ― | ― | $286.08K | <0.01% |
| ABIE | 1.14% | ― | ― | ― | $286.08K | <0.01% |
| RODE | 1.03% | ― | ― | ― | $173.16K | <0.01% |
| RODM | 0.90% | Hartford Multifactor Developed Markets (ex-US) ETF | $1.68B | 0.29% | $14.95M | 0.02% |
| FFLV | 0.81% | Fidelity Fundamental Large Cap Value ETF | $18.82M | 0.38% | $152.51K | <0.01% |
| AQEC | 0.69% | AQE Core ETF | $609.20M | 0.49% | $4.21M | <0.01% |
| GQEU | 0.65% | Goldman Sachs Alpha Enhanced Europe Equity Active UCITS ETF AccumEUR | $614.57M | 0.77% | $4.00M | <0.01% |
| GDEU | 0.65% | Goldman Sachs Alpha Enhanced Europe Equity Active UCITS ETF EUR | $105.28K | 0.91% | $4.00M | <0.01% |
| ACLU | 0.62% | ― | ― | ― | $115.08K | <0.01% |
| ACLE | 0.62% | ― | ― | ― | $115.08K | <0.01% |
| LST | 0.62% | Leuthold Select Industries ETF | $218.01M | 0.65% | $1.35M | <0.01% |
| AVEU | 0.62% | American Century ICAV - Avantis Europe Equity Ucits Etf | $39.57M | 0.26% | $245.44K | <0.01% |
| FFLC | 0.59% | Fidelity UCITS ICAV - Fidelity US Fundamental Large Cap Core UCITS ETF USD | $87.01M | 0.40% | $502.18K | <0.01% |
| AVIV | 0.57% | Avantis International Large Cap Value ETF | $2.07B | 0.25% | $11.83M | 0.01% |
| FFLC | 0.56% | Fidelity Fundamental Large Cap Core ETF | $1.26B | 0.38% | $7.03M | <0.01% |
| AVSD | 0.49% | Avantis Responsible International Equity ETF | $376.48M | 0.23% | $1.85M | <0.01% |
| FENI | 0.48% | Fidelity Enhanced International ETF | $11.69B | 0.28% | $55.68M | 0.06% |
| TOUS | 0.46% | T. Rowe Price International Equity ETF | $1.71B | 0.50% | $7.84M | <0.01% |
| SPWO | 0.45% | SP Funds S&P World (ex-US) ETF | $244.75M | 0.55% | $1.11M | <0.01% |
| AVNC | 0.40% | Avantis All International Core Equity ETF | $99.60M | 0.27% | $401.27K | <0.01% |
| FVD | 0.40% | First Trust Value Line Dividend Index Fund | $8.05B | 0.62% | $32.13M | 0.03% |
| FUD | 0.39% | 1st Tr AlphaUSDiv Un | $7.73M | 0.79% | $30.58K | <0.01% |
| AVDE | 0.36% | Avantis International Equity ETF | $19.65B | 0.23% | $70.71M | 0.07% |
| CADE | 0.33% | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | $1.17M | <0.01% |
| DDXM | 0.33% | Dimensional Funds ICAV - Dimensional Global ex US Core Equity Market UCITS ETF USD Acc | ― | 0.22% | $577.69K | <0.01% |
| APIE | 0.30% | ActivePassive International Equity ETF | $1.13B | 0.45% | $3.44M | <0.01% |
| TIER | 0.27% | T. Rowe Price International Equity Research ETF | $137.11M | 0.38% | $375.61K | <0.01% |
| DXIV | 0.26% | Dimensional International Vector Equity ETF | $232.54M | 0.30% | $596.38K | <0.01% |
| DFAX | 0.11% | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | $13.47M | 0.01% |
| FTLS | 0.10% | First Trust Long/Short Equity ETF | $2.66B | 1.38% | $2.71M | <0.01% |
| AVGC | 0.10% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $864.80K | <0.01% |
| AVUS | 0.10% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $864.80K | <0.01% |
| DIHP | 0.08% | Dimensional International High Profitability ETF | $6.60B | 0.27% | $4.96M | <0.01% |
| DDGC | 0.06% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $1.35M | <0.01% |
| GEQ | 0.06% | Cambria Global EW 2 ETF | $205.96M | 0.27% | $125.69K | <0.01% |
| DFSI | 0.02% | Dimensional International Sustainability Core 1 ETF | $1.18B | 0.24% | $270.51K | <0.01% |
| DFIC | 0.01% | Dimensional International Core Equity 2 ETF | $15.36B | 0.22% | $1.69M | <0.01% |
Popular ETF Comparisons
GSK ETF Exposure FAQ
What ETFs hold GlaxoSmithKline stock?
GlaxoSmithKline (GSK) is currently held by 62 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to GSK include VanEck (PPH), Polen (IDVZ) and Keating (KEAT).
Which ETF has the largest exposure to GSK?
The ETF with the largest exposure to GSK is VanEck (PPH), with approximately $45.51M in market value exposure.
How much GSK stock is held by ETFs?
ETFs currently hold approximately $63.36M worth of GlaxoSmithKline (GSK) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.